// App-Quantinova.ai

Sa1151 : Steroid-Free Remission in Adalimumab-Treated Pediatric Patients With Moderately to Severely Active Crohn's Disease in the IMAgINE 1 Trial

Researchers

Presenter

  • Wallace Crandall

Principal Investigators

  • Richard B. Colletti

  • Frank Ruemmele

  • William A. Faubion

  • Jeffrey S. Hyams

  • Andreas Lazar

  • Yao Li

  • Samantha Eichner

  • Roopal Thakkar

Medical Centers

  • Universite Sorbonne Paris-Cite, Hospital Necker-Enfants Malades, APHP, Paris, France

  • Nationwide Children's Hospital, Columbus, OH

  • Hospital for Sick Children, Toronto, ON, Canada

  • Connecticut Children's Medical Center, Hartford, CT

  • University of Vermont, Burlington, VT

  • Mayo Clinic, Rochester, MN

Locations

  • France

  • Canada

  • United States

Companies

  • AbbVie Inc.

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

  • Infliximab

Outcome

  • N/A

Study Design

  • open label

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved